# Novo Nordisk (NVO) total debt: DKK 130.96B in 2025

URL: https://funkfolio.com/stock/NVO/total-debt

> Novo Nordisk (NVO) total debt was DKK 130.96B at the end of fiscal 2025, up 27.4% from fiscal 2024. Year-by-year chart and table.

---

## Novo Nordisk (NVO) total debt

**Total debt · fiscal 2025:** DKK 130.96B at Dec 31, 2025

Novo Nordisk (NVO) carried total debt of DKK 130.96B at the end of fiscal 2025 (December 31, 2025). That is 27.4% higher than the DKK 102.79B of fiscal 2024. Figures as of 18 Nov 2026, 11:37 UTC, from Yahoo Finance.

### Key facts

- **Total debt, fiscal 2025:** DKK 130.96B
- **Change on fiscal 2024:** +27.4%
- **Highest on record:** DKK 130.96B fiscal 2025
- **Lowest on record:** DKK 25.78B fiscal 2022
- **Fiscal years on record:** 4 2022–2025

Figures as of 18 Nov 2026, 11:37 UTC. Statements from Yahoo Finance. Amounts are in DKK. Figures, not advice.

### Novo Nordisk total debt, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was DKK 130.96B in fiscal 2025 and the lowest DKK 25.78B in fiscal 2022.

Total debt was 0.7× shareholders' equity at the end of fiscal 2025.

### Total debt by fiscal year

### Novo Nordisk total debt, year by year

Novo Nordisk (NVO) total debt by fiscal year

| Fiscal year | Total debt | Change | Year ended | Debt ÷ equity |
| --- | --- | --- | --- | --- |
| 2025 | DKK 130.96B | 27.4% up | Dec 31, 2025 | 0.7× |
| 2024 | DKK 102.79B | 280.6% up | Dec 31, 2024 | 0.7× |
| 2023 | DKK 27.01B | 4.7% up | Dec 31, 2023 | 0.3× |
| 2022 | DKK 25.78B | — | Dec 31, 2022 | 0.3× |

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

### How it is calculated

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

### How to read it

Debt magnifies results in both directions — set it against cash, equity and the profit available to pay the interest rather than reading it alone.

### Total debt at health care companies of similar size

Total debt of Novo Nordisk and comparable companies

| Company | Total debt | Fiscal year |
| --- | --- | --- |
| [Gilead Sciences GILD](https://funkfolio.com/stock/GILD/total-debt) | $24.94B | 2025 |
| [Abbott Laboratories ABT](https://funkfolio.com/stock/ABT/total-debt) | $13.86B | 2025 |
| Novo Nordisk NVO | DKK 130.96B | 2025 |
| [Pfizer PFE](https://funkfolio.com/stock/PFE/total-debt) | $63.96B | 2025 |
| [Danaher DHR](https://funkfolio.com/stock/DHR/total-debt) | $19.70B | 2025 |

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

### Novo Nordisk, figure by figure

- [Novo Nordisk market cap](https://funkfolio.com/stock/NVO/market-cap)
- [Novo Nordisk revenue](https://funkfolio.com/stock/NVO/revenue)
- [Novo Nordisk earnings](https://funkfolio.com/stock/NVO/earnings)
- [Novo Nordisk earnings per share (EPS)](https://funkfolio.com/stock/NVO/eps)
- [Novo Nordisk P/E ratio](https://funkfolio.com/stock/NVO/pe-ratio)
- [Novo Nordisk P/S ratio](https://funkfolio.com/stock/NVO/ps-ratio)
- [Novo Nordisk P/B ratio](https://funkfolio.com/stock/NVO/pb-ratio)
- [Novo Nordisk free cash flow](https://funkfolio.com/stock/NVO/free-cash-flow)
- [Novo Nordisk operating margin](https://funkfolio.com/stock/NVO/operating-margin)
- [Novo Nordisk dividend](https://funkfolio.com/stock/NVO/dividend)
- [Novo Nordisk shares outstanding](https://funkfolio.com/stock/NVO/shares-outstanding)
- [Novo Nordisk cash on hand](https://funkfolio.com/stock/NVO/cash)
- [Novo Nordisk total assets](https://funkfolio.com/stock/NVO/total-assets)
- [Novo Nordisk return on equity (ROE)](https://funkfolio.com/stock/NVO/roe)
- [Novo Nordisk return on invested capital (ROIC)](https://funkfolio.com/stock/NVO/roic)

[Novo Nordisk (NVO) overview: price, valuation and scorecard](https://funkfolio.com/stock/NVO) [All health care companies by market value](https://funkfolio.com/companies/sector/health-care)

### Novo Nordisk total debt: questions and answers

**How much debt does Novo Nordisk have?**

Novo Nordisk (NVO) carried total debt of DKK 130.96B at the end of fiscal 2025 (December 31, 2025). That is 27.4% higher than the DKK 102.79B of fiscal 2024.

**What are the highest and lowest total debt figures on record for Novo Nordisk?**

Across the 4 fiscal years on record (2022–2025), the highest was DKK 130.96B in fiscal 2025 and the lowest DKK 25.78B in fiscal 2022.

**How does Novo Nordisk's debt compare with its equity?**

Total debt was 0.7× shareholders' equity at the end of fiscal 2025.

**How is Novo Nordisk's total debt calculated?**

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative. For Novo Nordisk it is on record here for 4 fiscal years, 2022 to 2025.

Fiscal years are named for the calendar year they end in.

### Learn: total debt

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- [Market cap vs enterprise value: what is the difference?](https://funkfolio.com/learn/markets/market-cap-vs-enterprise-value)

  Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- [Analyst price targets and ratings: what they mean](https://funkfolio.com/learn/stocks/analyst-price-targets)

  An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.

### Cite this page

Funkfolio, “Novo Nordisk (NVO) total debt”, data as of 18 November 2026. https://funkfolio.com/stock/NVO/total-debt

Underlying data: Yahoo Finance.
